mitomycin has been researched along with Carcinoma, Ductal, Breast in 10 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
Excerpt | Relevance | Reference |
---|---|---|
"Two hundred and sixteen T2 breast cancer patients were treated consecutively with surgery followed by 5'DFUR (600 mg/body/day) + tamoxifen (20 mg/body/day) for 2 years." | 3.70 | Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer. ( Akasaka, Y; Hata, Y; Nakanishi, Y; Ogita, M; Sasaki, F; Sawada, Y; Takahashi, H; Uchino, J; Yoshimoto, M, 2000) |
"We studied how gastric cancer tissues and cells changed as a result of preoperative chemotherapy." | 2.68 | [Influence of preoperative on gastric cancer tissues and cells]. ( Chen, Z; Li, G; Liu, F, 1997) |
"Secondary spontaneous pneumothorax (SSP) is a rare complication of chemotherapy for pulmonary metastases and to the best of our knowledge, only 28 cases have been described, most of which occurred in patients with osteosarcoma or germ cell tumors." | 2.41 | Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case. ( Ansaloni, L; Bazzocchi, R; Bini, A; Grazia, M; Stella, F; Zompatori, M, 2000) |
" From the dose-response curves, the 50% growth inhibition (IC50) level for each drug was estimated." | 1.29 | In vitro chemosensitivity of human pancreatic cancer cell lines. ( Oka, T; Sawabe, Y; Yamagishi, H; Yamaguchi, N; Yamamura, Y, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarado-Miranda, A | 1 |
Arrieta, O | 1 |
Gamboa-Vignolle, C | 1 |
Saavedra-Perez, D | 1 |
Morales-Barrera, R | 1 |
Bargallo-Rocha, E | 1 |
Zinser-Sierra, J | 1 |
Perez-Sanchez, V | 1 |
Ramirez-Ugalde, T | 1 |
Lara-Medina, F | 1 |
Wark, L | 1 |
Novak, D | 1 |
Sabbaghian, N | 1 |
Amrein, L | 1 |
Jangamreddy, JR | 1 |
Cheang, M | 1 |
Pouchet, C | 1 |
Aloyz, R | 1 |
Foulkes, WD | 1 |
Mai, S | 1 |
Tischkowitz, M | 1 |
Sørlie, T | 1 |
Perou, CM | 1 |
Fan, C | 1 |
Geisler, S | 1 |
Aas, T | 1 |
Nobel, A | 1 |
Anker, G | 1 |
Akslen, LA | 1 |
Botstein, D | 1 |
Børresen-Dale, AL | 1 |
Lønning, PE | 1 |
Wakiyama, S | 1 |
Shirabe, K | 1 |
Nagaie, T | 1 |
Vinnicombe, SJ | 1 |
MacVicar, AD | 1 |
Guy, RL | 1 |
Sloane, JP | 1 |
Powles, TJ | 1 |
Knee, G | 1 |
Husband, JE | 1 |
Sawabe, Y | 1 |
Yamagishi, H | 1 |
Yamaguchi, N | 1 |
Yamamura, Y | 1 |
Oka, T | 1 |
Cakmakli, S | 1 |
Ersöz, S | 1 |
Tuğ, T | 1 |
Karaayvaz, M | 1 |
Akgül, H | 1 |
Li, G | 1 |
Liu, F | 1 |
Chen, Z | 1 |
Bini, A | 1 |
Zompatori, M | 1 |
Ansaloni, L | 1 |
Grazia, M | 1 |
Stella, F | 1 |
Bazzocchi, R | 1 |
Hata, Y | 1 |
Takahashi, H | 1 |
Sasaki, F | 1 |
Ogita, M | 1 |
Uchino, J | 1 |
Yoshimoto, M | 1 |
Akasaka, Y | 1 |
Nakanishi, Y | 1 |
Sawada, Y | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Pilot Study: Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging[NCT02798484] | 61 participants (Actual) | Interventional | 2016-06-21 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for mitomycin and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Bilateral recurrent pneumothorax complicating chemotherapy for pulmonary metastatic breast ductal carcinoma: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cycloph | 2000 |
2 trials available for mitomycin and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Car | 1996 |
[Influence of preoperative on gastric cancer tissues and cells].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1997 |
7 other studies available for mitomycin and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplat | 2009 |
Heterozygous mutations in the PALB2 hereditary breast cancer predisposition gene impact on the three-dimensional nuclear organization of patient-derived cell lines.
Topics: Adolescent; Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, In | 2013 |
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2006 |
[A case of carcinomatous cardiac tamponade due to breast cancer treated with OK-432 and mitomycin C].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2007 |
In vitro chemosensitivity of human pancreatic cancer cell lines.
Topics: Aged; Antimetabolites; Antineoplastic Agents; Carcinoma, Ductal, Breast; Cisplatin; DNA Replication; | 1996 |
Intra-arterial infusion chemotherapy in the treatment of locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antine | 1997 |
Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combin | 2000 |